 |
KOTA KINABALU, Malaysia, Sept. 21, 2024 /PRNewswire/ -- European Wellness, a global leader in regenerative medicine and integrated healthcare, has inaugurated its latest and most advanced facility, the European Wellness New Premier Center, in Kota Kinabalu, Sabah. This landmark 60,000 square-foot center represents a significant leap forward for healthcare in Sabah and is set to play a crucial role in the global medical wellness tourism sector.
The grand opening ceremony was a notable event, attracting international attention and high-profile attendees. Sabah's Chief Minister YAB Datuk Seri Panglima Haji Hajiji Bin Haji Noor, Sabah State Minister of Finance, YB Datuk Seri Panglima Haji Masidi Manjun, Advisor to the President of the UAE, H.E. Dr. Khalid Abdulla Mubarak Albuainain Almazrouie, and other dignitaries were present to witness the unveiling of this cutting-edge facility. The center, a major investment by EW's founders, Prof. Dato' Sri Dr. Mike Chan and Prof. Dato' Sri Dr. Michelle Wong, is designed to integrate advanced medical science with the healing power of Sabah's natural environment, setting a new benchmark in global healthcare.
Chief Minister Hajiji praised the vision and commitment of the founders, emphasizing how the center will enhance Sabah's healthcare capabilities and position the region as a prominent destination for medical wellness tourism. "This facility is a game-changer for Sabah, combining state-of-the-art medical science with our unique natural environment," said Hajiji. "It not only strengthens our local healthcare sector but also boosts Sabah's standing on the global medical tourism map."
The center's opening is a strategic move that aligns with Sabah's broader goals of becoming a leading hub for advanced healthcare and medical wellness tourism. Sabah's strategic location in Southeast Asia, as part of the BIMP-EAGA and ASEAN regions, provides a significant advantage in attracting international investment and talent. "We are positioning Sabah at the forefront of the global health and wellness revolution," Hajiji added. "This investment reflects our commitment to enhancing life quality and fostering international collaboration in medical innovation."
Dr. Khalid Abdulla Mubarak highlighted the international significance of the European Wellness New Premier Center. "The advancements showcased here are truly groundbreaking," Dr. Khalid remarked. "Prof. Chan's work in targeted organ-specific stem cell therapy represents the future of healthcare set to revolutionize regenerative medicine and significantly improve healthcare outcomes globally."
Dr. Khalid emphasized the importance of making such advanced treatments more accessible. "Currently, stem cell therapy is costly and limited in availability. Expanding access and reducing costs are crucial steps in making these life-changing treatments available to a broader population," he noted. He also recognized Sabah's potential as a global medical wellness tourism destination, praising the combination of high-quality medical facilities and the region's natural beauty.
The center will offer an extensive range of services, including over 60 advanced regenerative medicine and holistic wellness therapies. It features cutting-edge technology and a team of over 300 professionals dedicated to delivering personalized healthcare solutions. This new facility is part of a larger expansion plan that includes the establishment of a biopharmaceutical manufacturing facility in Kota Kinabalu Industrial Park, with an investment of USD 80 million, doubling the workforce and further enhancing Sabah's status in the global healthcare landscape.
The European Wellness New Premier Center stands as a testament to international collaboration and innovation in healthcare. It not only aims to transform healthcare in Sabah but also to set new standards for medical wellness worldwide. EW's dedication to healthcare advancements positions it to transform global medical wellness tourism, ushering in a new health era for Sabah and beyond.
KOTA KINABALU, Malaysia, Sept. 21, 2024 /PRNewswire/ -- European Wellness, a global leader in regenerative medicine and integrated healthcare, has inaugurated its latest and most advanced facility, the European Wellness New Premier Center, in Kota Kinabalu, Sabah. This landmark 60,000 square-foot center represents a significant leap forward for healthcare in Sabah and is set to play a crucial role in the global medical wellness tourism sector.
The grand opening ceremony was a notable event, attracting international attention and high-profile attendees. Sabah's Chief Minister YAB Datuk Seri Panglima Haji Hajiji Bin Haji Noor, Sabah State Minister of Finance, YB Datuk Seri Panglima Haji Masidi Manjun, Advisor to the President of the UAE, H.E. Dr. Khalid Abdulla Mubarak Albuainain Almazrouie, and other dignitaries were present to witness the unveiling of this cutting-edge facility. The center, a major investment by EW's founders, Prof. Dato' Sri Dr. Mike Chan and Prof. Dato' Sri Dr. Michelle Wong, is designed to integrate advanced medical science with the healing power of Sabah's natural environment, setting a new benchmark in global healthcare.
Chief Minister Hajiji praised the vision and commitment of the founders, emphasizing how the center will enhance Sabah's healthcare capabilities and position the region as a prominent destination for medical wellness tourism. "This facility is a game-changer for Sabah, combining state-of-the-art medical science with our unique natural environment," said Hajiji. "It not only strengthens our local healthcare sector but also boosts Sabah's standing on the global medical tourism map."
The center's opening is a strategic move that aligns with Sabah's broader goals of becoming a leading hub for advanced healthcare and medical wellness tourism. Sabah's strategic location in Southeast Asia, as part of the BIMP-EAGA and ASEAN regions, provides a significant advantage in attracting international investment and talent. "We are positioning Sabah at the forefront of the global health and wellness revolution," Hajiji added. "This investment reflects our commitment to enhancing life quality and fostering international collaboration in medical innovation."
Dr. Khalid Abdulla Mubarak highlighted the international significance of the European Wellness New Premier Center. "The advancements showcased here are truly groundbreaking," Dr. Khalid remarked. "Prof. Chan's work in targeted organ-specific stem cell therapy represents the future of healthcare set to revolutionize regenerative medicine and significantly improve healthcare outcomes globally."
Dr. Khalid emphasized the importance of making such advanced treatments more accessible. "Currently, stem cell therapy is costly and limited in availability. Expanding access and reducing costs are crucial steps in making these life-changing treatments available to a broader population," he noted. He also recognized Sabah's potential as a global medical wellness tourism destination, praising the combination of high-quality medical facilities and the region's natural beauty.
The center will offer an extensive range of services, including over 60 advanced regenerative medicine and holistic wellness therapies. It features cutting-edge technology and a team of over 300 professionals dedicated to delivering personalized healthcare solutions. This new facility is part of a larger expansion plan that includes the establishment of a biopharmaceutical manufacturing facility in Kota Kinabalu Industrial Park, with an investment of USD 80 million, doubling the workforce and further enhancing Sabah's status in the global healthcare landscape.
The European Wellness New Premier Center stands as a testament to international collaboration and innovation in healthcare. It not only aims to transform healthcare in Sabah but also to set new standards for medical wellness worldwide. EW's dedication to healthcare advancements positions it to transform global medical wellness tourism, ushering in a new health era for Sabah and beyond.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
European Wellness Unveils Premier Medical Wellness Center in Kota Kinabalu, Sabah: A Landmark in Global Healthcare
European Wellness Unveils Premier Medical Wellness Center in Kota Kinabalu, Sabah: A Landmark in Global Healthcare
European Wellness Unveils Premier Medical Wellness Center in Kota Kinabalu, Sabah: A Landmark in Global Healthcare
KUALA LUMPUR, Malaysia, March 12, 2026 /PRNewswire/ -- As Malaysia commemorates National Rare Disease Day and marks the launch of the National Policy for Rare Diseases, long-term, sustainable care for individuals living with rare, complex genetic conditions is now gaining growing attention and interest from across public and private stakeholders.
Among the critical components of long-term care for certain rare genetic metabolic disorders is specialised nutrition, which is often a therapeutic necessity, rather than a dietary or lifestyle preference for many patients.
For individuals diagnosed with inborn errors of metabolism (IEM), strict dietary management forms part of lifelong treatment. These patients often require carefully calibrated specialised nutritional formulations to prevent metabolic complications, as these conditions could impair the body's ability to process certain nutrients.
Therefore, securing stable, reliable access to specialised nutrition is vital for more resilient care management of rare disease patients.
When Nutrition Becomes Essential Support
Unlike conventional dietary support, specialised nutrition for rare metabolic diseases is designed to meet highly specific biochemical requirements. Even minor disruptions in availability can affect disease management, particularly for paediatric patients whose growth and neurological development depend on precise dietary control.
According to Dr Ngu Lock Hock, Clinical Genetics Consultant and Head of the Genetics Department of Hospital Kuala Lumpur, patients with genetic metabolic disorders in Malaysia have historically depended heavily on imported specialised nutrition products.
"Many metabolic formulas and specialised dietary substitutes were sourced from overseas manufacturers. While they provided clinically necessary support, dependence on imports meant exposure to both supply vulnerabilities and higher costs," he said.
Imported formulations are often subject to currency fluctuations, transportation expenses, and international production constraints, and geopolitical tensions, all of which can contribute to an increased financial burden for families and healthcare institutions.
In addition, disruptions in global manufacturing or shipping logistics could further create uncertainty for caregivers managing lifelong conditions, complicating long-term care planning and continuity of support.
"In metabolic care, consistency is critical. Any interruption in access to specialised nutrition, whether due to supply delays or affordability challenges, creates stress for caregivers and potential clinical risk for patients," he added.
Addressing Supply Vulnerability and Building Local Production Capacity
Malaysia's reliance on imported specialised metabolic nutrition has reflected global patterns, where specialised formulations are often concentrated among a small number of international producers.
However, recent global supply chain disruptions have highlighted the need for stronger domestic resilience in essential healthcare components. While pharmaceutical supply security is frequently discussed, specialised nutrition, particularly for rare genetic metabolic disorders, remains much less visible in healthcare ecosystem resilience conversations.
The recently launched National Policy for Rare Diseases in Malaysia now provides a structured roadmap for strengthening Malaysia's rare disease healthcare ecosystem, including improving access to essential services and long-term support. Within this context, building local production capacity in specialised metabolic nutrition represents an essential area of system reinforcement.
In response to this, local production initiatives have begun to take shape among homegrown healthcare solutions providers to develop locally produced specialised nutrition solutions tailored for genetic metabolic disorders. Among them are protein-free specialised nutrition products manufactured in Malaysia under VALENS, a specialised nutrition brand by homegrown pharmaceutical and consumer health company Pharm-D Health Science.
Such local production initiatives aim to complement existing imported options by reducing dependence on singular foreign supply chains and improving domestic responsiveness to clinical needs, as local production can shorten supply timelines, enhance distribution stability, and allow closer collaboration between manufacturers and healthcare providers managing rare genetic metabolic conditions in Malaysia.
Industry observers note that strengthening domestic capability does not replace international innovation but rather creates a more balanced and resilient healthcare ecosystem for rare disease patients.
Supporting Long-Term Sustainability
For families living with rare genetic metabolic disorders, care management extends beyond hospital settings into daily life. Parents and caregivers meticulously monitor dietary intake, calculate nutrient allowances, and maintain strict adherence to prescribed nutritional regimens.
More stable access to specialised nutrition, therefore, plays a direct role in maintaining clinical stability and quality of life.
As Malaysia advances its rare disease agenda, reinforcing continuity of specialised nutrition supply aligns with broader goals of healthcare sustainability and system resilience.
Dr Ngu emphasised that multi-stakeholder collaboration remains central to this progress.
"Policy direction, clinical expertise, patient advocacy and responsible industry participation must work together to strengthen rare disease care. Building sustainable access to specialised nutrition is part of that collective responsibility," he said.
Towards a More Resilient Rare Disease Ecosystem
As Malaysia advances its rare disease healthcare agenda, experts emphasise that healthcare resilience must extend beyond pharmaceuticals and include other essential care components, such as specialised nutrition.
Strengthening domestic production capability in specialised nutrition, therefore, represents a much-needed practical step toward reinforcing that commitment.
As local capability continues to develop alongside global partnerships, Malaysia's rare disease healthcare ecosystem stands to benefit from greater stability, responsiveness, and preparedness, which in turn supports Malaysian patients and families of the rare disease community.
About Pharm-D Health Science (PDHS)
Founded in 2001, Pharm-D Health Science (PDHS) is a pharmaceutical and consumer health company specialising in specialised medicines, pharmaceuticals, healthcare and consumer health products. With a steadfast commitment to pioneering research, development, and manufacturing, PDHS offers a comprehensive array of solutions, including medications, over-the-counter medications, specialised nutrition, health supplements, and medical devices. Notably, PDHS is also a pioneer in postbiotics research and supply in Malaysia.
Beyond pharmaceuticals, the company provides healthcare and consumer health solutions under trusted house brands such as VALENS, ELDON, Lang Bragman, MedSkin, Reflux-G, Retane, and more. Ultimately, Pharm-D Health Science's dedication to scientific excellence and holistic healthcare is driven by the mission to make health and wellbeing accessible for all with science.
For more information about Pharm-D Health Science, please visit https://www.pharmdhs.com/
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Building Resilient Rare Disease Support in Malaysia with Pharm-D Health Science's VALENS Specialised Nutrition
